← Back to Search

Supportive Care for Lung Cancer

N/A

Waitlist Available

Led By Manali I Patel, MD

Research Sponsored by Palo Alto Veterans Institute for Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9 months after patient enrollment

Awards & highlights

Study Summary

This trial will test a new way of proactively managing symptoms and delivering evidence-based care to patients with thoracic cancers. The goal is to improve patient satisfaction, quality of life, and use of healthcare resources.

Who is the study for?

This trial is for lung cancer patients at VA Palo Alto, both newly diagnosed and those already receiving care. It's not open to those who won't get their oncology care at this center or can't consent to participate.Check my eligibility

What is being tested?

The study tests whether weekly phone calls to check on symptoms can improve patient satisfaction, increase engagement in their own care, enhance quality of life, and affect healthcare resource use.See study design

What are the potential side effects?

Since the intervention involves telephone assessments rather than medications or procedures, there are no direct medical side effects; however, some may experience discomfort discussing symptoms.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9 months after patient enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9 months after patient enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months after patient enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Symptom documentation

Secondary outcome measures

Change in Patient Activation using the validated Patient Activation Measure

Change in Quality of Life using the Functional Assessment of Cancer Therapy - Lung survey

Change in patient satisfaction with decision-making using the Satisfaction with Decision Survey

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Weekly telephone symptom assessmentExperimental Treatment1 Intervention

Each patient who is enrolled in the intervention will receive a weekly phone call from the Research Assistant for a total of 9 months to assess symptoms using the Edmonton Symptom Assessment Scale. Results of the symptom assessments will be provided to the clinic staff (RN and MD) for review each week. Symptom assessments will be documented into an encrypted, HIPAA compliant digital platform which provides longitudinal symptom data management and also provides symptom assessment tools for the clinical team in their intervention strategies. In addition, patients will complete symptom and quality of life surveys at 0, 3, 6 and 9 months.

Group II: Control ArmActive Control1 Intervention

Patients randomized to usual clinical care will receive standard of care for thoracic malignancies as provided by the VA Palo Alto Health Care System. Patients will complete outcome surveys at 0, 3, 6, and 9 months.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Weekly telephone symptom assessment

2017

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Palo Alto Veterans Institute for ResearchLead Sponsor

52 Previous Clinical Trials

7,845 Total Patients Enrolled

Carevive Systems, Inc.Industry Sponsor

15 Previous Clinical Trials

994 Total Patients Enrolled

Manali I Patel, MDPrincipal InvestigatorFaculty

Media Library

Weekly telephone symptom assessment Clinical Trial Eligibility Overview. Trial Name: NCT03216109 — N/A

Lung Cancer Research Study Groups: Control Arm, Weekly telephone symptom assessment

Lung Cancer Clinical Trial 2023: Weekly telephone symptom assessment Highlights & Side Effects. Trial Name: NCT03216109 — N/A

Weekly telephone symptom assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT03216109 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in the current clinical trial?

"Clinicaltrials.gov suggests that this clinical trial is not currently enrolling patients, with the initial posting dating back to August 20th 2017 and last update occurring on October 25th 2022. Although current recruitment has concluded for this particular study, there are 649 other trials in progress at present."

Answered by AI

Recent research and studies

Contemporary Clinical Trials CommunicationsJournal

Improving Supportive Care for Patients with Thoracic Malignancies – A Randomized Controlled Trial

Patel, Manali I., Lakedia Banks, and Millie Das. 2022. “Improving Supportive Care for Patients with Thoracic Malignancies – A Randomized Controlled Trial”. Contemporary Clinical Trials Communications. Elsevier BV. doi:10.1016/j.conctc.2022.100929.

clinicaltrials.govStudy

Improving Supportive Care For Patients With Thoracic Malignancies

Manali Patel 2017. "Improving Supportive Care For Patients With Thoracic Malignancies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03216109.